Serum protein levels of YKL-40 and plasma miR-214 expression in patients with systemic sclerosis

References

• Pattanaik D, Brown M, Postlethwaite BC, Postlethwaite EA. Pathogenesis of systemic sclerosis. Front Immunol. 2015;6:272.
   PubMed Web of Science ®Google Scholar
• Cutolo M, Soldano S, Smith V. Pathophysiology of systemic sclerosis: current understanding and new insights. Expert Rev Clin Immunol. 2019;15(7):753–64.
   PubMed Web of Science ®Google Scholar
• Kognole AA, Payne CM. Inhibition of mammalian glycoprotein YKL-40: identification of the physiological ligand. J Biol Chem. 2017;292(7):2624–36.
   PubMed Web of Science ®Google Scholar
• Shao R, Taylor SL, Oh DS, Schwartz LM. Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization. Oncotarget. 2015;6(38):40507–18.
   PubMedGoogle Scholar
• Nordenbaek C, Johansen JS, Halberg P, Wiik A, Garbarsch C, Ullman S, et al. High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement. Scand J Rheumatol. 2005;34(4):293–7.
   PubMed Web of Science ®Google Scholar
• Furukawa T, Matsui K, Kitano M, Yokoyama Y, Sekiguchi M, Azuma N, et al. Relationship between YKL-40 and pulmonary arterial hypertension in systemic sclerosis. Mod Rheumatol. 2019;29(3):476–83.
   PubMed Web of Science ®Google Scholar
• Ho YY, Baron M, Recklies AD, Roughley PJ, Mort JS. Cells from the skin of patients with systemic sclerosis secrete chitinase 3-like protein 1. BBA Clin. 2014;1:2–11.
   PubMedGoogle Scholar
• Chen JQ, Papp G, Szodoray P, Zeher M. The role of microRNAs in the pathogenesis of autoimmune diseases. Autoimmun Rev. 2016;15(12):1171–80.
   PubMed Web of Science ®Google Scholar
• Eichhorn SW, Guo H, McGeary SE, Ricard A, Rodriguez-Mias RA, Shin C, et al. mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues. Mol Cell. 2014;56(1):104–15.
   PubMed Web of Science ®Google Scholar
• Rebane A, Akdis CA. MicroRNAs: essential players in the regulation of inflammation. J Allergy Clin Immunol. 2013;132(1):15–26.
   PubMed Web of Science ®Google Scholar
• Hasegawa M. Biomarkers in systemic sclerosis: their potential to predict clinical courses. J Dermatol. 2016;43(1):29–38.
   PubMed Web of Science ®Google Scholar
• Wang M, Liu M, Ni T, Liu Q. miR-214 mediates vascular inflammation and apoptosis via PTEN expression. Mol Med Rep. 2018;18:2229–36.
   PubMed Web of Science ®Google Scholar
• Unlu S, Tang S, Wang E, Martinez I, Tang D, Bianch ME, et al. Damage associated molecular pattern molecule-induced microRNAs (DAMPmiRs) in human peripheral blood mononuclear cells. PLOS One. 2012;7(6):e38899.
   PubMed Web of Science ®Google Scholar
• Peoples C, Medsger TA Jr., Lucas M, Rosario ML, Feghali-Bostwick CA. Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes. J Scleroderma Relat Disord. 2016;1(2):177–240.
   PubMed Web of Science ®Google Scholar
• Royle JG, Lanyon PC, Grainge MJ, Abhishek A, Pearce FA. The incidence, prevalence, and survival of systemic sclerosis in the UK clinical practice research data link. Clin Rheumatol. 2018;37(8):2103–11.
   PubMed Web of Science ®Google Scholar
• Karalilova R, Kazakova M, Sapundzhieva T, Dichev V, Batalov Z, Sarafian V, et al. Serum YKL-40 and IL-6 levels correlate with ultrasound findings of articular and periarticular involvement in patients with systemic sclerosis. Rheumatol Int. 2019;39(11):1841–8.
   PubMed Web of Science ®Google Scholar
• Sun L, Wang D, Li H, She H. Significance of high YKL-40 expression regulated by miR-24 in cervical cancer progression and prognosis. Int J Clin Exp Pathol. 2016;9:5128–37.
   Web of Science ®Google Scholar
• Kim KC, Yun J, Son DJ, Kim JY, Jung JK, Choi JS, et al. Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1. Theranostics. 2018;8(16):4409–28.
   PubMed Web of Science ®Google Scholar
• Tan H, Yao H, Lie Z, Chen G, Lin S, Zhang Y. MicroRNA-30a-5p promotes proliferation and inhibits apoptosis of human pulmonary artery endothelial cells under hypoxia by targeting YKL-40. Mol Med Rep. 2019;20:236–44.
   PubMed Web of Science ®Google Scholar
• Lai NS, Yu HC, Tung CH, Huang KY, Huang HB, Lu MC. The role of aberrant expression of T cell miRNAs affected by TNF-α in the immunopathogenesis of rheumatoid arthritis. Arthritis Res Ther. 2017;19(1):261.
   PubMedGoogle Scholar
• Gulyaeva LF, Kushlinskiy NE. Regulatory mechanisms of microRNA expression. J Transl Med. 2016;14(1):143.
   PubMed Web of Science ®Google Scholar
• Miao CG, Xiong YY, Yu H, Zhang XL, Qin MS, Song TW, et al. Critical roles of microRNAs in the pathogenesis of systemic sclerosis: new advances, challenges and potential directions. Int Immunopharmacol. 2015;28(1):626–33.
   PubMed Web of Science ®Google Scholar
• Honda N, Jinnin M, Kajihara I, Makino T, Makino K, Masuguchi S, et al. TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts. J Immunol. 2012;188:3323–31.
   Google Scholar
• Li H, Yang R, Fan X, Gu T, Zhao Z, Chang D, et al. MicroRNA array analysis of microRNAs related to systemic scleroderma. Rheumatol Int. 2012;32(2):307–13.
   PubMed Web of Science ®Google Scholar
• Long H, Wang X, Chen Y, Wang L, Zhao M, Lu Q. Dysregulation of microRNAs in autoimmune diseases: pathogenesis, biomarkers and potential therapeutic targets. Cancer Lett. 2018;428:90–103.
   PubMed Web of Science ®Google Scholar
• Wermuth PJ, Piera-Velazquez S, Jimene SA. Exosomes isolated from serum of systemic sclerosis patients display alterations in their content of profibrotic and antifibrotic microRNA and induce a profibrotic phenotype in cultured normal dermal fibroblasts. Clin Exp Rheumatol 2017;35:21–30.
   PubMed Web of Science ®Google Scholar
• Koba S, Jinnin M, Inoue K, Nakayama W, Honda N, Makino K, et al. Expression analysis of multiple microRNAs in each patient with scleroderma. Exp Dermatol. 2013;22(7):489–91.
   PubMed Web of Science ®Google Scholar
• Anaparti V, Smolik I, Meng X, Spicer V, Mookherjee N, El-Gabalawy H. Whole blood microRNA expression pattern differentiates patients with rheumatoid arthritis, their seropositive first-degree relatives, and healthy unrelated control subjects. Arthritis Res Ther. 2017;19(1):249.
   PubMedGoogle Scholar
• Chouri E, Servaas NH, Bekker CPJ, Affandi AJ, Cossu M, Hillen MR, et al. Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis. J Autoimmun. 2018;89:162–70.
   PubMed Web of Science ®Google Scholar